Since the surge of the coronavirus pandemic all over the world, many are forced to resort to remote working and learning to prevent contracting and spreading the disease. As alternative working spaces are being sought after to maintain productivity, a psychologist says working from the comfort of one’s bed may be good.
Aside from having to work remotely or from home, the coronavirus pandemic has also affected the mental health of many, including those who are already suffering from related issues. Many have experienced worse bouts of their mental health issues take effect, which has also affected the way they work. According to new research, a way to maintain productivity and better mental health is by working from bed. This study was done by UK mattress brand OTTY, who conducted a survey and found that 25 percent of people spent a day working from bed during the lockdown.
They also found that a little before the announcement of the second lockdown, more people were working in their beds. The brand consulted with many experts and chiropractors to look into this method and found that there are benefits to working from the comfort of the bed. Such benefits include less stress due to the peaceful environment created by being in bed.
“Working from the comfort of your bed can create a safe calming space, particularly when anxiety is an issue,” said Kerry Quigley, a British Association for Counselling and Psychotherapy-accredited expert. “It can eliminate stressors such as commuting, distractions, and workplace politics. The removal of these stressors and the autonomy to structure your day enables better time management, increasing productivity, and improving job satisfaction.”
At the same time, pharmaceutical companies are determined to produce a coronavirus vaccine. However, as prevention is better than a cure, scientists are also looking into prevention methods in order to keep pandemics from happening in the future. Several scientists have recently brought up the technique of gene altering to give a person immunity from potential pandemic-causing diseases.
The technique may be through a few methods such as the CRISPR or CRISPER-Cas9, which would involve scientists editing the genome by altering the DNA. Another method is to “scramble” the genetic code that will result in the disabling of coronaviruses.


Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
China vs. NASA: The New Moon Race and What's at Stake by 2030
Tabletop particle accelerator could transform medicine and materials science
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 



